$1.22
-0.02-1.61%
At close: -
$1.10
-0.12-9.84%
After Hours: May 2, 8:00 AM EDT
Comments
Loading...
AN2 Therapeutics Stock Short Interest Report | NASDAQ:ANTX | Benzinga
Short interest in AN2 Therapeutics Inc (NASDAQ:ANTX) increased during the last reporting period, rising from 61.16K to 82.34K. This put 0.42% of the company's publicly available shares short.
Short interest in AN2 Therapeutics Corp (XNAS:ANTX) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 70.89K shares traded per day, it would take 1.16 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
82.34K
Short Interest %
0.42%
Days to Cover
1.16
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. Common | 04/15/2025 | 04/25/2025 | 0.42% | 19,505,504 | 82,335 | 70,887 | 1.16 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 03/31/2025 | 04/09/2025 | 0.31% | 19,505,504 | 61,160 | 80,512 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 03/14/2025 | 03/25/2025 | 0.37% | 19,285,674 | 71,203 | 159,678 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 02/28/2025 | 03/11/2025 | 0.58% | 19,285,674 | 112,040 | 157,667 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 02/14/2025 | 02/26/2025 | 0.41% | 19,285,674 | 78,578 | 156,231 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 01/31/2025 | 02/11/2025 | 0.31% | 19,285,674 | 58,838 | 115,411 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 01/15/2025 | 01/27/2025 | 0.41% | 19,285,674 | 78,586 | 125,357 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 12/31/2024 | 01/10/2025 | 0.47% | 19,285,674 | 90,026 | 184,833 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 12/13/2024 | 12/24/2024 | 0.38% | 19,285,674 | 74,084 | 285,614 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 11/29/2024 | 12/10/2024 | 0.37% | 19,285,674 | 71,424 | 1,774,853 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 11/15/2024 | 11/26/2024 | 1.97% | 19,285,674 | 379,597 | 566,814 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 10/31/2024 | 11/11/2024 | 0.69% | 19,249,215 | 133,574 | 216,444 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 10/15/2024 | 10/24/2024 | 0.72% | 19,249,215 | 139,119 | 101,884 | 1.37 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 09/30/2024 | 10/09/2024 | 0.98% | 19,249,215 | 188,480 | 220,915 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 09/13/2024 | 09/24/2024 | 1.30% | 19,249,215 | 249,628 | 282,866 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 08/30/2024 | 09/11/2024 | 0.76% | 19,249,215 | 146,885 | 885,933 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 08/15/2024 | 08/26/2024 | 2.01% | 19,249,215 | 386,842 | 1,737,193 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 07/31/2024 | 08/09/2024 | 3.55% | 19,235,824 | 683,402 | 188,636 | 3.62 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 07/15/2024 | 07/24/2024 | 3.59% | 19,235,824 | 690,674 | 203,391 | 3.4 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 06/28/2024 | 07/10/2024 | 3.52% | 19,235,824 | 676,962 | 90,446 | 7.48 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 06/14/2024 | 06/26/2024 | 3.68% | 19,235,824 | 707,266 | 79,678 | 8.88 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 05/31/2024 | 06/11/2024 | 3.88% | 19,235,824 | 746,870 | 236,533 | 3.16 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 05/15/2024 | 05/24/2024 | 3.61% | 19,235,824 | 693,840 | 104,803 | 6.62 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 04/30/2024 | 05/09/2024 | 3.83% | 19,235,824 | 736,895 | 99,952 | 7.37 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 04/15/2024 | 04/24/2024 | 2.39% | 19,235,824 | 460,513 | 482,798 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 03/28/2024 | 04/09/2024 | 1.32% | 20,644,536 | 272,509 | 361,327 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 03/15/2024 | 03/26/2024 | 1.55% | 20,615,606 | 319,420 | 403,978 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 02/29/2024 | 03/11/2024 | 1.43% | 20,615,606 | 295,295 | 628,906 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 02/15/2024 | 02/27/2024 | 1.63% | 20,615,606 | 336,249 | 896,768 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 01/31/2024 | 02/09/2024 | 1.36% | 20,615,606 | 280,320 | 103,908 | 2.7 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 01/12/2024 | 01/24/2024 | 1.47% | 20,615,606 | 302,100 | 91,259 | 3.31 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 12/29/2023 | 01/10/2024 | 1.43% | 20,615,606 | 294,389 | 96,859 | 3.04 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 12/15/2023 | 12/27/2023 | 0.81% | 20,615,606 | 166,643 | 148,678 | 1.12 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 11/30/2023 | 12/11/2023 | 1.37% | 20,615,606 | 282,097 | 65,700 | 4.29 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 11/15/2023 | 11/27/2023 | 1.55% | 20,615,606 | 319,018 | 38,207 | 8.35 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 10/31/2023 | 11/09/2023 | 1.24% | 20,580,391 | 255,770 | 26,863 | 9.52 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 10/13/2023 | 10/24/2023 | 1.11% | 20,580,391 | 227,447 | 41,597 | 5.47 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 09/29/2023 | 10/10/2023 | 0.64% | 20,580,391 | 131,462 | 128,188 | 1.03 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 09/15/2023 | 09/26/2023 | 0.77% | 20,580,391 | 159,232 | 75,143 | 2.12 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 08/31/2023 | 09/12/2023 | 0.75% | 20,580,391 | 153,704 | 82,033 | 1.87 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 08/15/2023 | 08/24/2023 | 0.65% | 20,580,391 | 133,791 | 8,544 | 15.66 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 07/31/2023 | 08/09/2023 | 1.32% | 10,300,613 | 135,683 | 22,390 | 6.06 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 07/14/2023 | 07/25/2023 | 1.54% | 10,300,613 | 158,643 | 31,168 | 5.09 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 06/30/2023 | 07/12/2023 | 2.04% | 10,300,613 | 210,047 | 412,806 | 1 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 06/15/2023 | 06/27/2023 | 3.76% | 10,300,613 | 387,639 | 64,488 | 6.01 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 05/31/2023 | 06/09/2023 | 3.24% | 10,300,613 | 333,871 | 36,326 | 9.19 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 05/15/2023 | 05/24/2023 | 2.58% | 10,300,613 | 265,535 | 39,893 | 6.66 | Get Alert |
| ANTX | AN2 Therapeutics, Inc. Common | 04/28/2023 | 05/09/2023 | 2.45% | 10,300,613 | 252,190 | 19,117 | 13.19 | Get Alert |
Looking for the most shorted stocks?
